Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids

European Journal of Neuroscience

Volumn 10, Issue 9, 1998, Pages 2825-2830

  Diana, M ^a   Melis, M ^b   Gessa, G L ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cannabinoids; Dopamine; Electrophysiology; Memory; Prefrontal cortex; Ventral tegmental area

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; ELECTRIC ACTIVITY; ELECTROPHYSIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; WORKING MEMORY;

ACTION POTENTIALS; ANIMALS; CANNABINOIDS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; INJECTIONS, INTRAVENOUS; MALE; MICROELECTRODES; MORPHOLINES; NAPHTHALENES; NEURONS; PIPERIDINES; PREFRONTAL CORTEX; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0032457965     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.1998.00292.x     Document Type: Article

References (24)

1. Block, R.I. & Ghoneim, M.M. (1993) Effects of chronic marijuana use on human cognition. Psychopharmacology, 110, 219-228.
2. Brozoski, T.J., Brown, R.M., Rosvold, H.E. & Goldman, P.S. (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science, 205 (4409), 929-932.
3. Bunney, B.S., Walters, J.R., Roth, R.H. & Aghajanian, G.K. (1973) Dopaminergic neurons. Effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther., 185, 560-571.
4. 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur. J. Pharmacol., 190, 259-262.
5. Chiodo, L.A. (1988) Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology. Neuroscience Biobehavioral Rev., 12, 49-91.
6. Chiodo, L.A., Bannon, M.J., Grace, A.A., Roth, R.H. & Bunney, B.S. (1984) Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience, 12(1), 1-16.
7. Collins, D.R., Pertwee, R.G. & Davies, S.N. (1994) The action of synthetic cannabinoids SR 141716A on the induction of long-term potentiation in the rat hippocampal slice. Eur. J. Pharmacol., 259, R7-R8.
8. Collins, D.R., Pertwee, R.G. & Davies, S.N. (1995) Prevention by the cannabinoid antagonist, SR 141716A, of cannabinoid-mediated blockade of long term potentiation in the rat hippocampal slice. Br. J. Pharmacol., 115, 869-870.
9. Daniel, D.G., Weinberger, D.R., Jones, D.W., Zigun, J.R., Coppola, R., Handel, S. et al. (1991) The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J. Neuroscience, 11, 1907-1917.
10. Deutch, A.Y. & Roth, R.H. (1990) The determinants of stress-induced activation of the prefrontal cortical dopamine system. In Vylings, H.B.M., Van Eden, F.G., de Bruin, J.P.C., Corner, M.A. & Feenstra, M.G.P. (eds), The Prefrontal Cortex: Its Structure, Function and Pathology. Elsevier, Amsterdam, pp. 367-403.
11. Dolan, R.J., Fletcher, P., Frith, C.D., Friston, K.J., Frackowiak, R.S.J. & Grasby, P.M. (1995) Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature, 378, 180-182.
12. French, E.D. (1997) Δ2-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett., 226, 159-162.
13. Gariano, R.F., Tepper, J.M., Sawyer, S.F., Young, S.J. & Groves, P.M. (1989) Mesocortical dopaminergic neurons. 1. Electrophysiological properties and evidence for soma-dendritic autoreceptors. Brain Res. Bull., 22, 511-516.
14. Cessa, G.L., Mascia, M.S., Casu, M.A. & Carta, G. (1997) Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. Eur. J. Pharmacol., 327(1), R1-R2.
15. 1 receptors. Eur. J. Pharmacol., 341, 39-44.
16. Gifford, A.N., Gardner, E.L. & Ashby, C.R. Jr (1997) The effect of intravenous administration of Delta-9-tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo in anesthetized rats. Neuropsychobiology, 36, 96-99.
17. Goldman-Rakic, P.S. (1987) The circuitry of primate prefrontal cortex and the regulation of behavior by representational memory. In Mountcastle, V.M. (ed.), Handbook of Physiology: The Nervous System. American Physiological Society, Bethesda, MD, pp. 373-417.
18. Gonon, F.G. (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience, 24(1), 19-28.
19. Grace, A.A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the ethiology of schizophrenia. Neuroscience, 41(1), 1-24.
20. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. & Rice, K.C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neuroscience, 11, 563-583.
21. 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology, 16(6), 426-432.
22. 9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex. Synapse, 28, 21-26.
23. 9-tetrahydrocannabinol on repeated acquisition and performance of response sequences and on self-reports in humans. Behav. Pharmacol., 5, 71-78.
24. Lichtman, A.H., Dirnen, K.R. & Martin, B.R. (1995) Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology, 119, 282-290.